Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Laboratory test, Magnetic resonance imaging head normal, Magnetic resonance imaging normal, Meralgia paraesthetica
Clinical narrative: brief leg paralysis episodes; acute small fiber sensory neuropathy; lost ability to control legs for under a couple of minutes with fall to ground; neuropathy; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Apr2021 (Lot number: EM9810) at the age of 58 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VIT C; VIT D [COLECALCIFEROL]; MELATONIN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8737, Location of injection: Arm Right), administration date: 01Apr2021, when the patient was 58 years old, for COVID-19 Immunization. The following information was reported: NEUROPATHY PERIPHERAL (medically significant) with onset Jun2021, outcome "recovered", described as "neuropathy"; MONOPLEGIA (medically significant) with onset Nov2021, outcome "recovered", described as "brief leg paralysis episodes"; SMALL FIBRE NEUROPATHY (medically significant) with onset Nov2021, outcome "recovered", described as "acute small fiber sensory neuropathy"; FALL (medically significant) with onset Jun2021, outcome "recovered", described as "lost ability to control legs for under a couple of minutes with fall to ground". The events "neuropathy", "brief leg paralysis episodes", "acute small fiber sensory neuropathy" and "lost ability to control legs for under a couple of minutes with fall to ground" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: cardiovascular autonomic function test: unknown results; electromyogram: unknown results; magnetic resonance imaging: unknown results; x-ray: unknown results. Therapeutic measures were taken as a result of neuropathy peripheral, monoplegia, small fibre neuropathy, fall including gabapentin.  Course of the event: Developed noticeable symptoms of neuropathy within 8 weeks of vaccine. In Nov2021 diagnosed with acute small fiber sensory neuropathy. Symptoms have occurred in feet, legs, hands, arms including numbness, coldness, burning, tingling, pinching, brief shock sensations (all over body), displacement sensations in feet, as well as 3 very brief leg paralysis episodes (lost ability to control legs for under a couple of minutes with fall to ground). Symptoms started in Jun or Jul2021 with very minor burning in front of both thighs, symptoms seemed to peak in Sep2021 (with all of symptoms listed above). In Oct2021 symptoms seemed to diminish somewhat but still included burning in feet, pinching in side of right thigh, burning on front of both thighs. Started Gabapentin in Nov2021, symptoms seem to have diminished with Gabapentin but still have ongoing burning in feet and sometimes mild burning in legs and arms.  Follow up information has been requested